Trials Sponsors Conditions Drugs Pricing

Conditions

Alopecia Alopecia Areata Alopecia Drugs Alopecia Totalis Alopecia Universalis Autoimmune Diseases Hair Diseases Hair Loss

Keywords

Alopecia AreataAlopecia TotalisAlopecia UniversalisSystemic treatmentRegistry

Outcome Measures

Primary Outcomes (2)

Effectiveness of systemic treatments
The primary study parameters and endpoints include assessing the short- and long-term effectiveness of various systemic treatments for alopecia areata. Effectiveness ranging from strong improvement to strong deterioration (5 categories).
A minimum of 10 years from last patient enrolled (every 3-6 months)
Safety of systemic treatments
The primary study parameters and endpoints include assessing the short- and long-term safety of various systemic treatments for alopecia areata. Measured by the number of participants with treatment-related adverse events.
A minimum of 10 years from last patient enrolled (every 3-6 months)

Secondary Outcomes (4)

Eligibility Criteria

Age16 Years+

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

All adult patients with alopecia areata starting/using systemic treatment, who are willing to provide voluntary informed consent prior to inclusion in the registry and comply with the requirements of the registry. All patients will be recruited in the dermatology outpatient clinics.

You may qualify if:

Diagnosed with alopecia areata;

Sponsors & Collaborators

Erasmus Medical Center
Otherlead

Study Sites (1)

Erasmus University Medical Center

Rotterdam, Netherlands

RECRUITING

DirkJan Hijnen, MD, PhDCONTACT0031 10 704 01 10 d.hijnen@erasmusmc.nl

MeSH Terms

Conditions

Alopecia AreataAlopecia universalisAlopeciaHair DiseasesAutoimmune Diseases

Condition Hierarchy (Ancestors)

HypotrichosisSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsImmune System Diseases

Central Study Contacts

DirkJan Hijnen, MD, PhD

CONTACT

0031 10 704 01 10 d.hijnen@erasmusmc.nl

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Target Duration: 50 Years
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal Investigator

Study Record Dates

First Submitted

February 12, 2024

First Posted

February 28, 2024

Study Start

January 17, 2024

Actual (reported)

Primary Completion

December 31, 2099

Estimated

Systemic Treatments for Alopecia Areata Registry

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (4)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (4)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations